 BOULDER, Colo., July 15, 2021 GLOBE NEWSWIRE -- Viridian Therapeutics, Inc. Nasdaq: VRDN, a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by todays therapies, today announced the appointment of Jennifer Moses, CPA to the Companys Board of Directors and as Chair of the Audit Committee. 